Eric P. Winer

Breast Cancer Treatment

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

CDK4/6 inhibition triggers anti-tumour immunity

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma